中文 | English
Return
Total: 2607 , 1/261
Show Home Prev Next End page: GO
Author:(Bo, FENG)

1.DPP-4 inhibitors and glucose homeostasis - From cell to bedside

Bo FENG

Chinese Journal of Endocrinology and Metabolism 2012;28(6):525-526

3.Segmental splenectomy, the first choice for treatment of splenic benign tumor

Bo HUANG ; Bianxi FENG

Chinese Journal of Hepatobiliary Surgery 2010;16(6):410-412

4.Liraglutide alleviates arteriosclerotic lesions and inhibits receptor for advanced glycation end-product expression in diabetic ApoE-/- mice

Peicheng LI ; Bo FENG

Chinese Journal of Endocrinology and Metabolism 2016;32(8):680-684

5.13C-octanoic acid breath test for measurement of solid gastric emptying: reproducibility in normal subjects and patients with diabetes mellitus

Bo, FENG ; Ziegler, DAN

Chinese Journal of Nuclear Medicine 2001;21(2):107-108

6.Relationships among measures of gait recovery and community integration index in people with brain injury

Bo FENG ; Wei XU

Chinese Journal of Primary Medicine and Pharmacy 2015;(14):2203-2205

7.Inhibitory effect of 4'-methylether-scutellarein on human choriocarcinoma JAR cells and the possible mechanism

Bo FENG ; Changfen XU

Chinese Journal of Cancer Biotherapy 2006;0(05):-

8.An clinical analysis of gastrointestinal stromal tumors

Huiqin SHEN ; Bo FENG

Chinese Journal of General Surgery 2017;32(7):553-556

9.The influence of continuous quality improvement on nutritional status and renal function and low protein diet adherence in patients with chronic kidney disease

Sue CHEN ; Bo FENG

Journal of Endocrine Surgery 2014;(2):167-169

10.Diagnosis and interventional treatment for diabetic peripheral vascular disease

Maoquan LI ; Bo FENG

Journal of Interventional Radiology 2006;0(07):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 2607 , 1/261 Show Home Prev Next End page: GO